MEDNAX, INC. 4
4 · MEDNAX, INC. · Filed Jun 3, 2016
Insider Transaction Report
Form 4
Clark David A.
COO / Pediatrix Division
Transactions
- Sale
Common Stock
2016-06-01$67.78/sh−11,470$777,465→ 20,025 total - Award
Common Stock
2016-06-01+9,928→ 31,495 total
Footnotes (3)
- [F1]Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance based criteria but will not vest any earlier than in three equal installments on June 1, 2017, June 1, 2018 and June 1, 2019.
- [F2]Sales made pursuant to Reporting Person's 105b-1 trading plan.
- [F3]Sales of shares were made in thirty-six separate transactions with prices ranging from $67.53 to $67.95 for a weighted average sales price of $67.7825.